We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+24.53%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$7.44B
AUM Growth
+$2.18B
Cap. Flow
+$1.12B
Cap. Flow %
15.11%
Top 10 Hldgs %
13.07%
Holding
2,045
New
726
Increased
371
Reduced
415
Closed
520

Sector Composition

Rank Sector Weight
1 Financials 19.3%
2 Technology 16.73%
3 Consumer Discretionary 13.16%
4 Industrials 8.74%
5 Healthcare 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNF icon
426
Fidelity National Financial
FNF
$13.8B
$4.33M 0.06%
115,302
-12,686
-10% -$428K
FVAM
427
DELISTED
5:01 Acquisition Corp
FVAM
$4.32M 0.06%
+425,000
New +$4.29M
SUI icon
428
Sun Communities
SUI
$14.7B
$4.3M 0.06%
28,300
+20,416
+259% +$2.95M
FLACU
429
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$4.3M 0.06%
+414,300
New +$4.32M
NOVA
430
DELISTED
Sunnova Energy
NOVA
$4.3M 0.06%
+95,200
New +$3.3M
IT icon
431
Gartner
IT
$11.6B
$4.27M 0.06%
26,657
+21,499
+417% +$3.1M
HES
432
DELISTED
Hess
HES
$4.25M 0.06%
80,585
-261,393
-76% -$11.9M
ZBRA icon
433
Zebra Technologies
ZBRA
$17.4B
$4.25M 0.06%
+11,043
New +$3.72M
FCAC
434
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
$4.22M 0.06%
+400,000
New +$4.15M
WTRG icon
435
Essential Utilities
WTRG
$11.2B
$4.2M 0.06%
88,853
-36,735
-29% -$1.63M
SPHR icon
436
Sphere Entertainment
SPHR
$5.58B
$4.18M 0.06%
39,846
-12,636
-24% -$965K
NVO
437
Novo Nordisk
NVO
$201B
$4.17M 0.06%
+119,400
New +$4.13M
ZM icon
438
Zoom
ZM
$29.3B
$4.15M 0.06%
12,300
-2,015
-14% -$898K
MREO
439
Mereo BioPharma
MREO
$47.2M
$4.14M 0.06%
1,158,000
+814,805
+237% +$2.04M
BILI icon
440
Bilibili
BILI
$7.78B
$4.13M 0.06%
48,202
-177,399
-79% -$10.4M
LAZ icon
441
Lazard
LAZ
$4.28B
$4.13M 0.06%
97,551
+32,251
+49% +$1.22M
ASND icon
442
Ascendis Pharma A/S
ASND
$16.3B
$4.11M 0.06%
24,620
-3,295
-12% -$545K
INTU icon
443
Intuit
INTU
$87.2B
$4.1M 0.06%
10,785
+85
+0.8% +$29.9K
MRSN
444
DELISTED
Mersana Therapeutics
MRSN
$4.08M 0.05%
6,133
+2,427
+65% +$1.35M
CADE
445
DELISTED
Cadence Bancorporation
CADE
$4.07M 0.05%
248,012
+66,112
+36% +$876K
MS icon
446
Morgan Stanley
MS
$342B
$4.07M 0.05%
59,343
-293,355
-83% -$16.8M
ONC
447
BeOne Medicines Ltd
ONC
$36.4B
$4.06M 0.05%
+15,700
New +$4.32M
OBDC icon
448
Blue Owl Capital
OBDC
$5.56B
$4.05M 0.05%
319,900
+254,800
+391% +$3.23M
QQQ icon
449
Invesco QQQ Trust
QQQ
$479B
$4.03M 0.05%
+12,838
New +$3.77M
FFIV icon
450
F5
FFIV
$23.3B
$4.02M 0.05%
22,830
+2,899
+15% +$440K

Similar funds

Schonfeld Strategic Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Schonfeld Strategic Advisors held 2,045 positions worth $7.44B, up 42% from $5.25B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.12B of net new capital in Q4 2020, opening 726 new positions and adding to 371 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Crown Holdings, an estimated $43.8M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 272,911 shares worth $102M.
  • Schonfeld Strategic Advisors added most to US Bancorp in Q4 2020, an estimated $62.4M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2020 reduction was Crown Holdings, cutting an estimated $43.8M.
  • Schonfeld Strategic Advisors fully exited Claritev Corp in Q4 2020, selling an estimated $30.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $7.44B portfolio in Q4 2020.
  • Schonfeld Strategic Advisors opened 726 new positions and closed 520 in Q4 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 42% quarter-over-quarter to $7.44B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.